Navigation Links
Dual Lock™ (Single And Double) Pivot Under-Table Shield

ProductsDual Lock™ (Single And Double) Pivot Under-Table Shield
Company AliMed, Inc.
Item Dual Lock™ (Single And Double) Pivot Under-Table Shield
Features 
  • Provides a side wing of up to 23.6" wide
  • Dual Locking Handles for better mounting adjustment
  • Dual Lock Single Pivot Under-Table Shield 60 cm(23.6") A variation on undertable protection, this single jointed shield
  • offers a single protective pivoting shield 60 cm (24") wide by 71 cm (28") high and a 60 cm (24") wide by 9" high removable top panel
    • Description Primarily designed to prevent lower body exposure to scattered radiation. Dual Lock™ Shields may be used on any table where X-ray fluoroscopy is used. These shields are especially valuable for added protection in applications where C-arm fluoroscopy units are used. Three sizes of lower body table shields are offered, each equipped with a 17 cm wide mounting bracket that can slide and lock onto a table side accessory rail. Exclusive Dual Lock Mount system makes it easy to securely level shields on any conventional size accesory rail. Flexible 0.5 mm lead-equivalent overlapping curtains are attached to an aluminum alloy pivoting arm. Some arms are double jointed and can pivot at two points in order to conform to the shape of the tables. The arm can also swivel away from the table to form a side wing.
    Info AliMed, Inc.
    Customer Service: (800) 225-2610
    Web site: http://www.alimed.com/

    Related medicine products :

    1. Inter-Lock™ System
    2. Uric Acid (Uricase) (Single Reagent)
    3. Cholesterol (Single reagent)
    4. SPRING-GRIP™ (Single Use Non-conductive Anchoring Devices)
    5. SURGINEEDLE™ (Single Use Pneumoperitoneum Needles)
    6. VERSAPORT™ Plus V2 (Single Use Converterless Trocar System)
    7. VERSAPORT™ Plus RPF (Single Use Converterless Trocar System)
    8. VERSAPORT™ Plus V2 RT (Single Use Obturators)
    9. VISIPORT™ Plus RPF (Single Use Optical Trocar With VERSAPORT™ Plus RPF Converterless Trocar Sleeve)
    10. BLUNTPORT Plus (Single Use Converterless 5 mm-12 mm Trocar System for Open Laparoscopy)
    11. THORACOPORT™ (Single Use Trocars With Non-conductive Sleeves)
    Marlin' Cervical Orthosis ensures comfort and immobilization with its semirigid molded polyethylene anterior frame and occipital component. Two-piece design allows free air flow and easy application.
    Exo-Deluxe Overhead Traction for hospital or home care. Twice the clearance of other units between the patient and supporting wall. 2" nylon pulleys with polypropylene cord, head halter, spreader bar
    ...e Relief Padding&trade is perfect for use for ligh...terials or used to line braces, prosthetics, ortho...nst shock and vibration and conforms to all body c...g and chaffing. It is a 2mm thick gel sheet with a...
    This lightweight, full length 10" elastic binder has a variety of applications. Its most common use is as an abdominal binder for post-surgical dressings. It is effective in supporting abdominal co
    Medicine Products:
    (Date:7/25/2008)...weight or obese is not only a personal issue that ...ssue that impacts other people in society. A new s...eals that the extra Medicare cost associated with ...t financial burden on tax payers, costing up to hu...rrent Medicare population. , The article,s find...
    (Date:7/25/2008)...ers tips and encourages them to, ,Speak Up,(TM) f... 25 /PRNewswire-USNewswire/ -- The Pennsylvania,Pa...tient Safety Day" which,is a national effort to en... fully in their healthcare by asking questions and...or illness., "We understand the important role th...
    (Date:7/25/2008)...ber of jobs created in the medical field slowed in...nt kind of slowdown: they laid off fewer people in... Seattle, WA (PRWEB) July 25, 2008 -- Thoug...slowed in June overall, pharmaceutical companies r...music to the ears of sales representatives: fewer ...
    (Date:7/25/2008)... of Defense and Federal Agencies in, the executio...oenix is a, four-day, multi-agency collaborative... and local agencies with large and complex inciden...ital, ad-hoc, secure mobile communications infra...ORFOLK, Va., July 25 /PRNewswire/ -- Dataline LLC ...
    Breaking Medicine News(10 mins):Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3
    ...e improvement in patients who undergo yoga program...y proving the age-old belief about the interrelati...nsiderable improvement in the quality of life of t...ga program than those who do not. The study, prese...
    ...f Disease in Childhood says ‘Low birthweight babie...become hyperactive and with low attention spans’ a...ntion span, and impulsive behaviour characterise t...er, or HKD for short. It is one of the most common...
    ...ntification of a starter hormone responsible for i...moths//. The research was led by David Champlin, ...Maine, and assisted by students Paul Allee of Port...hree colleagues who are professors at the Universi...
    ...ologist and brain injury expert died on Wednesday ... standards to determine whether a patient was in a...his family the cause of death was complications of...rd had long been an advocate for the right of term...
    Other Medicine News:Health News:Yoga Along with Treatment for Breast Cancer Improves Quality of Life 2Health News:Yoga Along with Treatment for Breast Cancer Improves Quality of Life 3Health News:Hormone Transforming Caterpillars to Moths Identified 2Health News:Renowned Doctor Passes Away 2
    (Date:7/22/2008)...Latest awards under Therapeutics Development Initi...rations to 23; next deadline January 20,2009, NE... of its mission to,speed delivery of transformativ...he Michael J. Fox Foundation for Parkinson,s Resea...ix industry research teams. The awards,were grante...
    (Date:7/22/2008)...wo Regimens Including Lantus(R) and Apidra(R) Resu... with Type 2 Diabetes, Whatever the Algorithm ....J., July 22 /- Results from the "Adj...Simple Algorithm to Carbohydrate,Counting for Adju...published in the American Diabetes Association,s (...
    (Date:7/22/2008)... Developed and Validated by Columbia University Me...Proprietary MicroRNA Technology, The Test Differ... Lung Cancer (NSCLC), Classifying Squamous-Cell C... Percent and Specificity of 90 Percent,This is the...s, Sensitivity as Biomarkers for Accurate...
    (Date:7/22/2008)...Pilot Study Suggests That Ekkyo,s New Approach of ...ally Improve Scar Healing Physiology, MARSEILLES,...nown as,Heatwave Technology) a photomedicine compa...ems for skin scar prevention and reduction, announ...in Lasers in Surgery and Medicine*,reporting the r...
    Breaking Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3Center for Poverty Research to study senior hunger in America 2387 1Center for Poverty Research to study senior hunger in America 2387 2Weight Loss Can Control Hypertension 2385 1Weight Loss Can Control Hypertension 2385 2Weight Loss Can Control Hypertension 2385 3National Trichotillomania Awareness Week Gives Help and Hope to Hair Pullers 2382 1National Trichotillomania Awareness Week Gives Help and Hope to Hair Pullers 2382 2Connecticut Bishops Back Down over Provision of Emergency Contraception 2379 1Connecticut Bishops Back Down over Provision of Emergency Contraception 2379 2
    ...mbination Therapy Significantly Decreased Tumor Bl...e Tumors -, LOS ANGELES and TUSTIN, Calif., April ...aceuticals, Inc. , a,clinical stage biopharmaceuti...ies for the treatment of cancer and hepatitis C,vi...cal data,presented at the Centennial Annual Meetin...
    ...GARY, April 17, 2007 /PRNewswire-FirstCall/ - Onco...a poster by Dr. Maureen,E. Lane et al. of , New Yo...ovirus and Gemcitabine in Ras-Mutated Human HCT116... the American,Association for Cancer Research (AAC...runs from April 14-18, 2007. , The researchers fou...
    Other Medicine Technology:Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 2Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 3Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 4Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 5Oncolytics Biotech Inc. Research Collaborators Demonstrate,Reovirus/Gemcitabine Combination Has Synergistic Effect Against,Human Colon Cancer Cell Lines 2Oncolytics Biotech Inc. Research Collaborators Demonstrate,Reovirus/Gemcitabine Combination Has Synergistic Effect Against,Human Colon Cancer Cell Lines 3